Can TÜRK, Müfide OKAY, Seyhan TÜRK, Elif Sena TEMİRCİ, Osama JAWAD, Salih AKSU, Nilgün SAYINALP, İbrahim Celalettin HAZNEDAROĞLU

The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases

Turkish Journal of Medical Sciences

2019-Cilt: 49 - Sayı: 2

661-674

Lymphoma, ruxolitinib, JAK/STAT signaling pathway

133 130